ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Administered By

Awarded By

Contributors

Start/End

  • June 8, 2021 - June 13, 2024